{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:37:17Z","timestamp":1774589837524,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"DOI":"10.7759\/cureus.105937","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:46:56Z","timestamp":1774583216000},"source":"Crossref","is-referenced-by-count":0,"title":["IgA Nephropathy With a Membranoproliferative Glomerulonephritis Pattern Associated With Autoimmune Hepatitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Hiroya","family":"Adachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Noishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hozue","family":"Ehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Tamagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Sonomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00430547","article-title":"Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part","volume":"392","author":"Nakamoto Y","year":"1981","unstructured":"Nakamoto Y, Iida H, Kobayashi K, Dohi K, Kida H, Hattori N, Takeuchi J. Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Arch A Pathol Anat Histol. 1981, 392:45-54. 10.1007\/BF00430547","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.02.1397","article-title":"Clinical presentation, pathological spectrum, and outcomes of alcoholic cirrhosis-related immunoglobulin A nephropathy","volume":"9","author":"Ronsin C","year":"2024","unstructured":"Ronsin C, Braud P, Kandel-Aznar C, et al.. Clinical presentation, pathological spectrum, and outcomes of alcoholic cirrhosis-related immunoglobulin A nephropathy. Kidney Int Rep. 2024, 9:1369-78. 10.1016\/j.ekir.2024.02.1397","journal-title":"Kidney Int Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-025-02213-9","article-title":"Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis","volume":"38","author":"Umezawa Y","year":"2025","unstructured":"Umezawa Y, Aoki R, Ichikawa D, Suzuki Y, Suzuki T. Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis. J Nephrol. 2025, 38:1737-42. 10.1007\/s40620-025-02213-9","journal-title":"J Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i43.5783","article-title":"Association of liver cirrhosis related IgA nephropathy with portal hypertension","volume":"13","author":"Kalambokis G","year":"2007","unstructured":"Kalambokis G, Christou L, Stefanou D, Arkoumani E, Tsianos EV. Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol. 2007, 13:5783-6. 10.3748\/wjg.v13.i43.5783","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.02.030","article-title":"Secondary IgA nephropathy","volume":"94","author":"Saha MK","year":"2018","unstructured":"Saha MK, Julian BA, Novak J, Rizk DV. Secondary IgA nephropathy. Kidney Int. 2018, 94:674-81. 10.1016\/j.kint.2018.02.030","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072726","article-title":"Secondary IgA nephropathy and IgA-associated nephropathy: a systematic review of case reports","volume":"12","author":"Tota M","year":"2023","unstructured":"Tota M, Baron V, Musial K, et al.. Secondary IgA nephropathy and IgA-associated nephropathy: a systematic review of case reports. J Clin Med. 2023, 12:10.3390\/jcm12072726","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i17.3828","article-title":"Autoimmune hepatitis in a patient with immunoglobulin A nephropathy: a case report","volume":"8","author":"Jeon YH","year":"2020","unstructured":"Jeon YH, Kim DW, Lee SJ, et al.. Autoimmune hepatitis in a patient with immunoglobulin A nephropathy: a case report. World J Clin Cases. 2020, 8:3828-34. 10.12998\/wjcc.v8.i17.3828","journal-title":"World J Clin Cases"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.10.012","article-title":"Secondary IgA nephropathy shares the same immune features with primary IgA nephropathy","volume":"5","author":"Wang M","year":"2020","unstructured":"Wang M, Lv J, Zhang X, Chen P, Zhao M, Zhang H. Secondary IgA nephropathy shares the same immune features with primary IgA nephropathy. Kidney Int Rep. 2020, 5:165-72. 10.1016\/j.ekir.2019.10.012","journal-title":"Kidney Int Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70382","article-title":"Immunoglobulin A nephropathy: Molecular pathogenesis and targeted therapy","volume":"6","author":"Zhou XJ","year":"2025","unstructured":"Zhou XJ. Immunoglobulin A nephropathy: Molecular pathogenesis and targeted therapy. MedComm (2020). 2025, 6:e70382. 10.1002\/mco2.70382","journal-title":"MedComm (2020)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2007.03.010","article-title":"Elevated serum BAFF levels in patients with autoimmune hepatitis","volume":"68","author":"Migita K","year":"2007","unstructured":"Migita K, Abiru S, Maeda Y, et al.. Elevated serum BAFF levels in patients with autoimmune hepatitis. Hum Immunol. 2007, 68:586-91. 10.1016\/j.humimm.2007.03.010","journal-title":"Hum Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2023.1346769","article-title":"The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies","volume":"3","author":"Cheung CK","year":"2023","unstructured":"Cheung CK, Barratt J, Liew A, Zhang H, Tesar V, Lafayette R. The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies. Front Nephrol. 2023, 3:1346769. 10.3389\/fneph.2023.1346769","journal-title":"Front Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.512277","article-title":"Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes","volume":"289","author":"Suzuki H","year":"2014","unstructured":"Suzuki H, Raska M, Yamada K, et al.. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem. 2014, 289:5330-9. 10.1074\/jbc.M113.512277","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02306-0","article-title":"Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sj\u00f6gren's syndrome: a case report","volume":"22","author":"Nishioka R","year":"2021","unstructured":"Nishioka R, Hara S, Kawahara H, et al.. Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sj\u00f6gren's syndrome: a case report. BMC Nephrol. 2021, 22:108. 10.1186\/s12882-021-02306-0","journal-title":"BMC Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000546196","article-title":"Association between rheumatoid arthritis and the incidence of IgA nephropathy","volume":"56","author":"Azegami T","year":"2025","unstructured":"Azegami T, Kaneko H, Okada A, et al.. Association between rheumatoid arthritis and the incidence of IgA nephropathy. Am J Nephrol. 2025, 56:773-82. 10.1159\/000546196","journal-title":"Am J Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.12.007","article-title":"Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity","volume":"10","author":"Neves M","year":"2011","unstructured":"Neves M, Alves JD. Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity. Autoimmun Rev. 2011, 10:375-82. 10.1016\/j.autrev.2010.12.007","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/474747-iga-nephropathy-with-a-membranoproliferative-glomerulonephritis-pattern-associated-with-autoimmune-hepatitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:47:00Z","timestamp":1774583220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/474747-iga-nephropathy-with-a-membranoproliferative-glomerulonephritis-pattern-associated-with-autoimmune-hepatitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.105937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}